Jalal Alghabra, PA
Physician Assistant · Fredericksburg, VANPI 1023497880
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Johnson & Johnson at 46.3% of the total. Among physician assistant clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 864 payments — averaging $137.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$55K
- E.r. Squibb & Sons, L.L.C.$21K
- Janssen Scientific Affairs, LLC$15K
- AbbVie$11K
- Arcutis Biotherapeutics, Inc.$6K
- UCB, Inc.$2K
- plus $9K from 24 others
What the payments were for
- Consulting fees$14,08812%
- Speaking & faculty fees$69,05358%
- Travel & lodging$18,65216%
- Food & beverage$16,43514%
- Education$4090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 128 | $54,913 |
| E.r. Squibb & Sons, L.L.C. | 113 | $21,093 |
| Janssen Scientific Affairs, LLC | 32 | $14,900 |
| AbbVie(2 entities) | 175 | $11,013 |
| Arcutis Biotherapeutics, Inc. | 41 | $5,831 |
| UCB, Inc. | 74 | $2,039 |
| Galderma Laboratories, L.p. | 20 | $1,829 |
| EPI Health, LLC | 2 | $1,017 |
| Regeneron Healthcare Solutions, Inc. | 24 | $750 |
| Novartis | 38 | $687 |
| Pfizer | 31 | $537 |
| Journey Medical Corporation | 2 | $517 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $505 |
| Sun Pharmaceutical Industries Inc. | 25 | $458 |
| Sanofi | 17 | $444 |
| Dermavant Sciences, Inc. | 55 | $367 |
| Lilly USA, LLC | 15 | $352 |
| Incyte Corporation | 20 | $327 |
| Amgen | 10 | $265 |
| LEO Pharma Inc. | 10 | $235 |
| Verrica Pharmaceuticals Inc. | 4 | $148 |
| Kerecis Limited | 3 | $95 |
| Organon | 10 | $77 |
| Boehringer Ingelheim | 4 | $76 |
| Convatec Inc. | 2 | $44 |
| Organogenesis Inc. | 1 | $43 |
| VYNE Pharmaceuticals Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $17 |
| Strata Skin Sciences, Inc. | 2 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$118,637 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TremfyaGuselkumab | 28 | $381,440 |
| Skyrizi PenRisankizumab-Rzaa | 16 | $322,436 |
| Humira(Cf) PenAdalimumab | 15 | $176,292 |
| Dupixent SyringeDupilumab | 42 | $160,075 |
| Dupixent PenDupilumab | 41 | $152,130 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 17 | $123,888 |
| Clobetasol Propionate | 409 | $30,474 |
| Metronidazole | 95 | $6,065 |
| Tretinoin | 52 | $4,403 |
| Ketoconazole | 177 | $3,859 |
| Fluorouracil | 59 | $3,048 |
| Triamcinolone Acetonide | 233 | $2,219 |
| Tacrolimus | 16 | $2,168 |
| Doxycycline Hyclate | 90 | $1,937 |
| Betamethasone Valerate | 77 | $1,914 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $54,913 | $381,44028 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Fredericksburg
- Leah WallerFredericksburg$18K
- Kaitlin GilbertFredericksburg$13K
- Denise HamiltonFredericksburg$12K
- Monica SpellmanFredericksburg$12K
- John DalessandroSalem$160K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.